Name: Good Genes Gone Bad: A Short History of Vaccines and Biological Drugs That Have Transformed Medicine de Narendra Chirmule(Ebury pr) (en Inglés)
SKU: 61990413
Price: 488.63 MXN
Availability: InStock
Author: Chirmule Narendra
ISBN: 9780670096039

portada Good Genes Gone Bad: A Short History of Vaccines and Biological Drugs That Have Transformed Medicine de Narendra Chirmule(Ebury pr) (en Inglés)

Good Genes Gone Bad: A Short History of Vaccines and Biological Drugs That Have Transformed Medicine de Narendra Chirmule(Ebury pr) (en Inglés)

Formato

Libro Físico

Editorial

Ebury Pr

Autor

Chirmule Narendra

Idioma

Inglés

Encuadernación

Tapa Dura

ISBN13

9780670096039

Good Genes Gone Bad: A Short History of Vaccines and Biological Drugs That Have Transformed Medicine de Narendra Chirmule(Ebury pr) (en Inglés)

Chirmule Narendra (Autor) · Ebury Pr · Tapa Dura

Libro Nuevo Importado

Envío: 18 a 24 días háb.

$ 888.41$ 488.63

-45%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 19 unidades

$ 488.63

Llega entre el 18 Sep y el 29 Sep a CUAUHTÉMOC, Ciudad de México. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Good Genes Gone Bad: A Short History of Vaccines and Biological Drugs That Have Transformed Medicine de Narendra Chirmule(Ebury pr) (en Inglés)"

The field of biotechnology has evolved over the past four decades, developing medicines which are curing diseases. But this journey of success has been tough and arduous, built upon the shoulders of major failures. Good Genes Gone Bad highlights seven such colossal failures in drug development-all of which culminated in the development of novel drugs-weaving together various analogies through the stories and thus allowing the reader to understand complex biological phenomena. These stories include treatment of medical conditions such as genetic clotting disorder (haemophilia), childhood-diarrhoea (rotavirus vaccine), preventing HIV infection, activation of the immune systems to treat cancer, gene therapy for treatment of diseases caused by gene-defects/mutations, cell therapy for treatment of leukaemias, and finally the success of Biocon's approval of the first biologic drug for breast cancer. Written by the former R&D head of Biocon, India's largest pharmaceutical company, Good Genes Gone Bad is a fascinating look at the complex world of medicine and drug development, providing the readers with a sense of magnitude of challenges and the extent of difficulty that it takes to make novel medicines.